DE602006021628D1 - Verbesserte synthese und zubereitungen von duloxetinsalzen - Google Patents
Verbesserte synthese und zubereitungen von duloxetinsalzenInfo
- Publication number
- DE602006021628D1 DE602006021628D1 DE602006021628T DE602006021628T DE602006021628D1 DE 602006021628 D1 DE602006021628 D1 DE 602006021628D1 DE 602006021628 T DE602006021628 T DE 602006021628T DE 602006021628 T DE602006021628 T DE 602006021628T DE 602006021628 D1 DE602006021628 D1 DE 602006021628D1
- Authority
- DE
- Germany
- Prior art keywords
- duloxetin
- preparations
- salts
- improved synthesis
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74909505P | 2005-12-12 | 2005-12-12 | |
US74909605P | 2005-12-12 | 2005-12-12 | |
US74909705P | 2005-12-12 | 2005-12-12 | |
US81585406P | 2006-06-23 | 2006-06-23 | |
US81583506P | 2006-06-23 | 2006-06-23 | |
US81585606P | 2006-06-23 | 2006-06-23 | |
PCT/IB2006/004250 WO2007119114A2 (en) | 2005-12-12 | 2006-12-12 | Improved synthesis and preparations of duloxetine salts |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006021628D1 true DE602006021628D1 (de) | 2011-06-09 |
Family
ID=38437735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006021628T Active DE602006021628D1 (de) | 2005-12-12 | 2006-12-12 | Verbesserte synthese und zubereitungen von duloxetinsalzen |
Country Status (9)
Country | Link |
---|---|
US (4) | US20090182156A1 (de) |
EP (3) | EP1971593A2 (de) |
AR (1) | AR058321A1 (de) |
AT (1) | ATE507215T1 (de) |
CA (3) | CA2634008A1 (de) |
DE (1) | DE602006021628D1 (de) |
IL (3) | IL192114A0 (de) |
PL (1) | PL1971592T3 (de) |
WO (3) | WO2007096707A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1856087A1 (de) | 2005-03-08 | 2007-11-21 | Teva Pharmaceutical Industries Limited | Kristallformen von (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamin-oxalat und deren herstellung |
MX2007011255A (es) | 2005-03-14 | 2007-10-18 | Teva Pharma | Clohidrato de duloxetina puro. |
EP1838692A2 (de) | 2005-09-22 | 2007-10-03 | Teva Pharmaceutical Industries Ltd | Dnt-maleat und herstellungsverfahren dafür |
EP2100888A3 (de) | 2005-12-05 | 2011-01-19 | Teva Pharmaceutical Industries Ltd. | Verfahren zur Herstellung von Duloxetin-Hydrochlorid |
PL1971592T3 (pl) | 2005-12-12 | 2011-09-30 | Medichem Sa | Ulepszona synteza i preparaty soli duloksetyny |
US7560573B2 (en) | 2006-02-21 | 2009-07-14 | Teva Pharmaceutical Industries Ltd | Process for the preparation of (S)-(-)-N,N-dimethyl-3-(2-thienyl)-3-hydroxypropananine, a duloxetine intermediate |
HU228458B1 (en) | 2006-03-13 | 2013-03-28 | Egis Gyogyszergyar Nyrt | Duloxetine salts for producing pharmaceutical compositions |
WO2007134168A2 (en) * | 2006-05-10 | 2007-11-22 | Dr. Reddy's Laboratories Ltd. | Process for preparing duloxetine |
WO2009019719A2 (en) * | 2007-08-09 | 2009-02-12 | Ind-Swift Laboratories Limited | Process for the preparation of 3-aryloxy-3-arylpropanamines |
EP2107057A1 (de) | 2008-04-04 | 2009-10-07 | Ranbaxy Laboratories Limited | Verfahren zur Herstellung von reinem Duloxetin |
WO2011092065A1 (en) * | 2010-01-29 | 2011-08-04 | Nicox S.A. | Nitric oxide releasing compounds for the treatment of neurophatic pain |
CN103896910B (zh) * | 2012-12-27 | 2016-02-03 | 成都国弘医药有限公司 | 一种度洛西汀的合成方法 |
CN103524480B (zh) * | 2013-10-21 | 2016-04-20 | 山东鲁药制药有限公司 | 一种盐酸度洛西汀的制备方法 |
CN104478849A (zh) * | 2014-02-14 | 2015-04-01 | 广东东阳光药业有限公司 | 制备去甲肾上腺素再摄取双重抑制剂的方法 |
JP2016172704A (ja) * | 2015-03-17 | 2016-09-29 | 株式会社トクヤマ | デュロキセチン塩酸塩の製造方法、及び新規な結晶構造のデュロキセチン塩酸塩 |
CN107382958B (zh) * | 2017-07-05 | 2021-11-09 | 浙江华海药业股份有限公司 | 一种度洛西汀中间体的结晶方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
HU9202128D0 (en) | 1992-06-26 | 1992-10-28 | Richter Gedeon Vegyeszet | Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine |
US5362886A (en) | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
ATE309196T1 (de) | 1999-04-09 | 2005-11-15 | Lilly Co Eli | Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte |
US20040053948A1 (en) * | 2002-05-10 | 2004-03-18 | Cytokinetics, Inc. | Compounds, compositions and methods |
AU2003258109A1 (en) * | 2002-08-06 | 2004-02-23 | Teva Pharmaceutical Industries Ltd. | Novel crystalline forms of gatifloxacin |
GB0229583D0 (en) * | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
GB0410470D0 (en) * | 2004-05-11 | 2004-06-16 | Cipla Ltd | Pharmaceutical compound and polymorphs thereof |
WO2006027798A2 (en) | 2004-08-05 | 2006-03-16 | Sun Pharmaceutical Industries Limited | A process for preparation of an antidepressant compound |
CZ297560B6 (cs) | 2004-10-26 | 2007-02-07 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu) |
EP1730132A2 (de) | 2004-12-23 | 2006-12-13 | Teva Pharmaceutical Industries Ltd | Verfahren zur herstellung pharmazeutisch unbedenklicher salze von duloxetin und zwischenprodukten davon |
MX2007011255A (es) | 2005-03-14 | 2007-10-18 | Teva Pharma | Clohidrato de duloxetina puro. |
EP1838692A2 (de) | 2005-09-22 | 2007-10-03 | Teva Pharmaceutical Industries Ltd | Dnt-maleat und herstellungsverfahren dafür |
PL1971592T3 (pl) | 2005-12-12 | 2011-09-30 | Medichem Sa | Ulepszona synteza i preparaty soli duloksetyny |
CZ299270B6 (cs) * | 2006-01-04 | 2008-06-04 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
-
2006
- 2006-12-12 PL PL06850470T patent/PL1971592T3/pl unknown
- 2006-12-12 AT AT06850470T patent/ATE507215T1/de not_active IP Right Cessation
- 2006-12-12 DE DE602006021628T patent/DE602006021628D1/de active Active
- 2006-12-12 CA CA002634008A patent/CA2634008A1/en not_active Abandoned
- 2006-12-12 US US12/097,245 patent/US20090182156A1/en not_active Abandoned
- 2006-12-12 EP EP06850472A patent/EP1971593A2/de not_active Withdrawn
- 2006-12-12 EP EP06850470A patent/EP1971592B1/de not_active Revoked
- 2006-12-12 WO PCT/IB2006/004194 patent/WO2007096707A2/en active Application Filing
- 2006-12-12 WO PCT/IB2006/004250 patent/WO2007119114A2/en active Application Filing
- 2006-12-12 US US12/097,251 patent/US20090093645A1/en not_active Abandoned
- 2006-12-12 US US12/097,247 patent/US20090221668A1/en not_active Abandoned
- 2006-12-12 EP EP06849529A patent/EP1971591A2/de not_active Withdrawn
- 2006-12-12 CA CA002634009A patent/CA2634009A1/en not_active Abandoned
- 2006-12-12 AR ARP060105468A patent/AR058321A1/es not_active Application Discontinuation
- 2006-12-12 WO PCT/IB2006/004252 patent/WO2007119116A2/en active Application Filing
- 2006-12-12 CA CA002634007A patent/CA2634007A1/en not_active Abandoned
-
2008
- 2008-06-12 IL IL192114A patent/IL192114A0/en unknown
- 2008-06-12 IL IL192115A patent/IL192115A0/en unknown
- 2008-06-12 IL IL192116A patent/IL192116A0/en unknown
-
2010
- 2010-04-16 US US12/762,131 patent/US8158808B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007096707A2 (en) | 2007-08-30 |
US8158808B2 (en) | 2012-04-17 |
IL192114A0 (en) | 2009-08-03 |
EP1971591A2 (de) | 2008-09-24 |
EP1971592A2 (de) | 2008-09-24 |
EP1971593A2 (de) | 2008-09-24 |
CA2634007A1 (en) | 2007-08-30 |
CA2634008A1 (en) | 2007-10-25 |
US20100286412A1 (en) | 2010-11-11 |
WO2007119116A2 (en) | 2007-10-25 |
IL192115A0 (en) | 2009-08-03 |
EP1971592B1 (de) | 2011-04-27 |
CA2634009A1 (en) | 2007-10-25 |
WO2007096707A3 (en) | 2008-01-24 |
WO2007119114A3 (en) | 2008-01-24 |
WO2007119116A3 (en) | 2008-01-31 |
ATE507215T1 (de) | 2011-05-15 |
PL1971592T3 (pl) | 2011-09-30 |
US20090221668A1 (en) | 2009-09-03 |
WO2007119114A2 (en) | 2007-10-25 |
US20090182156A1 (en) | 2009-07-16 |
IL192116A0 (en) | 2009-08-03 |
AR058321A1 (es) | 2008-01-30 |
US20090093645A1 (en) | 2009-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006021628D1 (de) | Verbesserte synthese und zubereitungen von duloxetinsalzen | |
DE602006012450D1 (de) | Exo- und diastereoselektive synthese von himbacin-analoga | |
ATE365169T1 (de) | Regioselektive synthese von cci-779 | |
ATE472527T1 (de) | Synthese und verwendungen von 2-oxo-4- methylthiobuttersäure, deren salze und deren derivate | |
DK1913001T3 (da) | (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf | |
DE60313289D1 (de) | Kontrollierte synthese von ziprasidon | |
ATE486853T1 (de) | Synthese von acylaminoalkenylenamiden als substanz-p-antagonisten | |
ATE521612T1 (de) | Synthese von boronsäureester- und boronsäureverbindungen | |
CY2017048I2 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
ATE540952T1 (de) | Pyrroloä2,3-düpyrimidinderivate, ihre zwischenprodukte und synthese | |
ATE500249T1 (de) | Synthese von himbacinanaloga | |
DE602006018970D1 (de) | Hunde-influenza-virus und relevante zusammensetzungen und anwendungsverfahren | |
IL192361A0 (en) | Improved synthesis and preparations of metoprolol and its salts | |
NO20055643D0 (no) | Preparation of lodixanol | |
ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
DK1833495T3 (da) | Dermatologisk anvendelse af mælkeproteiner | |
DE602005020603D1 (de) | Synthese von trithiocarbonat-raft-agentia und zwischenprodukte daraus | |
DE602005025521D1 (de) | Synthese von aminosäure-n-carboxyanhydriden | |
DE602005005645D1 (de) | Stereoselektive synthese von vitamin-d-analoga | |
DE602006013028D1 (de) | Lösungsphasensynthese von leuprolid und dessen zwischenprodukten | |
ATE459627T1 (de) | Synthesen und herstellungen von narwedin und verwandten neuen verbindungen | |
ATE497504T1 (de) | Aminoderivate von b-homoandrostanen und b- heteroandrostanen | |
DE602006006853D1 (de) | Synthese von neuem Dihydrobenzoxazin | |
ATE402145T1 (de) | Synthese von pyrrol-2-carbonsäurenitrilen | |
ATE520397T1 (de) | Therapeutische kombinationen aus manidipin und simvastatin |